Form D · Biotechnology
Viratech Corp.
Stockton, CA · CIK 0001130781
Offering snapshot reported Oct 8, 2013 · SEC filing
- Reported sold
- $147K Offering amount: $2.5M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $2.5K Reported outside-investor minimum
- First sale
- Feb 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2013 | Initial | $147,000 | No comparison | 23 | SEC filing |
| Jan 29, 2013 | Initial | $114,200 | No comparison | 19 | SEC filing |
| May 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 24, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 29, 2004 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204204
Source: Form D, filed Oct 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Buckman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4719 Quail Lakes Drive #G319
Stockton, CA, 95207
Stockton, CA, 95207